Search results: Sage Journals

Open accessResearch articleFirst published 2024

Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysis

Evi Zhuleku, Daniel Wirth, Riikka Nissinen [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published 2026

Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study

Simone Parisi, Andrea Becciolini, Bernardo D’Onofrio [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2022

Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol

Megan Clowse, Rebecca Fischer-Betz, Catherine Nelson-Piercy [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2022

Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure

Dong-Jin Park, Sung-Eun Choi, Ji-Hyoun Kang [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2021

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study

Patricia Bogas, Chamaida Plasencia-Rodriguez, Victoria Navarro-Compán [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessReview articleFirst published 2020

Tuberculosis and targeted synthetic or biologic DMARDs,beyond tumor necrosis factor inhibitors

Gerasimos Evangelatos, Vasiliki Koulouri, Alexios Iliopoulos [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2021

Factors affecting drug survival of an alternative TNF inhibitor and secukinumab in patients with ankylosing spondylitis switching from the first TNF inhibitor

Oh Chan Kwon, Jung Hwan Park, Min-Chan Park

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2026

Persistence of IL-17 and TNF inhibitors following initial TNF inhibitor use in axial spondyloarthritis: a nationwide retrospective cohort study

Yu-Seon Jung, Soo-Kyung Cho, Se Rim Choi [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2021

Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis

Alberto Migliore, Giuseppe Pompilio, Davide Integlia [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published December, 2022

Anti tumor necrosis factor induced focal myositis

Adrian Mark Masnammany, Wendy Lau, Peter Kee Kee Wong [...]

Proceedings of Singapore Healthcare

Open accessResearch articleFirst published 2024

Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysis

Evi Zhuleku, Daniel Wirth, Riikka Nissinen [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published 2026

Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study

Simone Parisi, Andrea Becciolini, Bernardo D’Onofrio [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2022

Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol

Megan Clowse, Rebecca Fischer-Betz, Catherine Nelson-Piercy [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2022

Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure

Dong-Jin Park, Sung-Eun Choi, Ji-Hyoun Kang [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2021

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study

Patricia Bogas, Chamaida Plasencia-Rodriguez, Victoria Navarro-Compán [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessReview articleFirst published 2020

Tuberculosis and targeted synthetic or biologic DMARDs,beyond tumor necrosis factor inhibitors

Gerasimos Evangelatos, Vasiliki Koulouri, Alexios Iliopoulos [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2021

Factors affecting drug survival of an alternative TNF inhibitor and secukinumab in patients with ankylosing spondylitis switching from the first TNF inhibitor

Oh Chan Kwon, Jung Hwan Park, Min-Chan Park

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2026

Persistence of IL-17 and TNF inhibitors following initial TNF inhibitor use in axial spondyloarthritis: a nationwide retrospective cohort study

Yu-Seon Jung, Soo-Kyung Cho, Se Rim Choi [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2021

Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis

Alberto Migliore, Giuseppe Pompilio, Davide Integlia [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published December, 2022

Anti tumor necrosis factor induced focal myositis

Adrian Mark Masnammany, Wendy Lau, Peter Kee Kee Wong [...]

Proceedings of Singapore Healthcare